He tested the compound against 80 different RNAsites until he found its perfect match: a 20-unit strip of nucleotides adjacent to the RNA coding region for PKC-alpha.
And though the company earlier had spurned a biotech firm's proposal to jointly study Muckle-Wells, Wright convinced his bosses that the obscure disorder was the perfect test-bed for the new compound.